Established in 1891, the Washington State Pharmacy Quality Assurance Commission (WA Pharmacy Commission) regulates the practice of pharmacy, and the distribution, manufacturing, and delivery of pharmaceuticals within and into the state. The commission protects and promotes public health and safety by issuing licenses, registrations, and certifications to qualified persons and entities and responding to complaints or reports of unprofessional conduct. The Commission is assigned the authority to enforce and change the schedule of controlled substances in Washington state.
Washington State Pharmacy Quality Assurance Commission
(WA Pharmacy Commission)
Public
Structural Relationships
-
-
Washington State Pharmacy Quality Assurance Commission
(WA Pharmacy Commission) -
Washington State Pharmacy Quality Assurance Commission Legislative CommitteeInactive
(WA Pharmacy Commission Legislative Committee) -
Washington State Pharmacy Quality Assurance Commission Legislative Task Force
(WA Pharmacy Commission Legislative Task Force)
Observations
The Week Ahead
(April 7, 2025)
Planned committee activity for the 2025 regular session would draw to a close on Tuesday as regulators struggled to rescind authority over labs while also expanding reporting requirements.
The Week Ahead
(March 31, 2025)
Before the next cutoff on Wednesday, senators would consider the WSLCB lab authority bill just as agency Enforcement tried to stretch that authority to encompass non-mandatory samples.
The Week Ahead
(March 24, 2025)
A busy week was planned for cannabis-related legislation and budgets at the legislature while the City of Lynnwood had fallen behind on an effort to open for retail businesses.
The Week Ahead
(March 17, 2024)
Legislators appeared in no hurry to consider cannabis-related bills from the opposite house but regulatory bodies planned to provide updates and signal research directions.
The Week Ahead
(March 10, 2024)
As the legislature raced ahead, other entities would be addressing product samples, medical cannabis, the retail ban in Lynnwood, and a new ethics policy at WSLCB.
The Week Ahead
(March 3, 2024)
As legislators considered moving legislation out of the house of origin including nine cannabis-related bills, WSLCB members would discuss “Efficiencies” in their public meetings.
The Week Ahead
(February 24, 2024)
Of five cannabis-related bills requiring movement before the next cutoff, two were scheduled for initial hearings while the WSLCB Board planned to take up rulemaking on three projects.
The Week Ahead
(February 17, 2024)
Eight cannabis-related bills were scheduled for hearings and six potential executive sessions were planned in the week before the House of Origin Policy Committee Cutoff.
The Week Ahead
(February 10, 2024)
Three cannabis-related bills were scheduled to be heard and four executive sessions were planned for the week which would include cancellations of most regular WSLCB meetings.
The Week Ahead
(February 3, 2025)
Five cannabis bills would receive hearings in the fourth week of the 2025 session, while regulators trimmed lab accreditation rules and briefed lawmakers on technology challenges.